2-[4-[3-[(ethenylsulfonylamino)methyl]pyrrolidin-1-yl]sulfonylphenyl]-N-(2-phenylethyl)acetamide
C23H29N3O5S2 — CID 146210755
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[3-[(ethenylsulfonylamino)methyl]pyrrolidin-1-yl]sulfonylphenyl]-N-(2-phenylethyl)acetamide
2-[4-[3-[(ethenylsulfonylamino)methyl]pyrrolidin-1-yl]sulfonylphenyl]-N-(2-phenylethyl)acetamide (PubChem CID 146210755) has the molecular formula C23H29N3O5S2 and a molecular weight of 491.64 g/mol. Its IUPAC name is 2-[4-[3-[(ethenylsulfonylamino)methyl]pyrrolidin-1-yl]sulfonylphenyl]-N-(2-phenylethyl)acetamide.
Molecular Properties
| Compound Name | 2-[4-[3-[(ethenylsulfonylamino)methyl]pyrrolidin-1-yl]sulfonylphenyl]-N-(2-phenylethyl)acetamide |
|---|---|
| PubChem CID | 146210755 |
| Molecular Formula | C23H29N3O5S2 |
| Molecular Weight | 491.64 g/mol |
| Exact Mass | 491.15 |
| IUPAC Name | 2-[4-[3-[(ethenylsulfonylamino)methyl]pyrrolidin-1-yl]sulfonylphenyl]-N-(2-phenylethyl)acetamide |
| SMILES | C=CS(=O)(=O)NCC1CCN(S(=O)(=O)c2ccc(CC(=O)NCCc3ccccc3)cc2)C1 |
| InChI | InChI=1S/C23H29N3O5S2/c1-2-32(28,29)25-17-21-13-15-26(18-21)33(30,31)22-10-8-20(9-11-22)16-23(27)24-14-12-19-6-4-3-5-7-19/h2-11,21,25H,1,12-18H2,(H,24,27) |
| InChIKey | MLXSJDBBRVWTCL-UHFFFAOYSA-N |
| XLogP | 1.66 |
| TPSA | 112.65 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 491.64 |
| LogP ≤ 5 | 1.66 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146210755 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.